Zcash (ZEC) and Aptos (APT) are sliding while Pomerdoge (POMD) has been firm and drawing investor interest. Notably, POMD prices have doubled as more analysts monitor the project’s progress.
Zcash under pressure
ZEC remains under pressure and is currently trading at $29. It is down 1.53% in the past week and 60% over the last year.
There are multiple factors contributing to the decline in Zcash’s price. While its privacy features are appealing, they can be exploited for illicit activities like money laundering, which harms its reputation and attractiveness to investors.
Moreover, competition from newer privacy-focused cryptocurrencies that offer enhanced features has caused an investor shift, impacting ZEC.
Aptos free-falling
APT, the native currency of Aptos, a layer-1 proof-of-stake (PoS) blockchain employing the Rust-based Move programming language, is down over 7% this month.
The coin’s 24-hour trading volume is also down 8.8%, indicating falling interest. APT is changing hands at $6.68, down 1.08% and 5.29 in the last 24 hours and week, respectively.
Trading volume decline signals investor caution, which may negatively impact APT prices.
Pomerdoge is rising
Pomerdoge’s ecosystem is centered around Pomergame, a platform that offers rewards for competitive gaming.
Pomerdoge offers rewards, including a chance to win a $50,000 POMD mega prize. Weekly competitions and giveaways enhance its appeal.
These offerings position Pomerdoge as an option for players in the blockchain play-to-earn (P2E) gaming sector. The demand for POMD is also rising as more users trade. Additionally, 7,777 non-fungible tokens (NFTs) exclusively available to POMD holders can offer more opportunities.
Industry experts are bullish, expecting more gains in the future after the launch. Presently, POMD is available for $0.007 in the ongoing presale.
Find out more about the Pomerdoge (POMD) presale:
Website: https://pomerdoge.com/
Telegram Community: https://t.me/pomerdoge
Disclosure: This content is provided by a third party. crypto.news does not endorse any product mentioned on this page. Users must do their own research before taking any actions related to the company.
